Funding: This work was supported in part by a grant from NovaBay Pharmaceuticals to the Center for Medical Mycology, Case Western Reserve University.
Efficacy of NVC-422 in the treatment of dermatophytosis caused by Trichophyton mentagrophytes using a guinea pig model
Article first published online: 17 APR 2013
© 2013 The International Society of Dermatology
International Journal of Dermatology
Volume 52, Issue 5, pages 567–571, May 2013
How to Cite
Ghannoum, M. A., Long, L., Cirino, A. J., Miller, A. R., Najafi, R., Wang, L., Sharma, K., Anderson, M. and Memarzadeh, B. (2013), Efficacy of NVC-422 in the treatment of dermatophytosis caused by Trichophyton mentagrophytes using a guinea pig model. International Journal of Dermatology, 52: 567–571. doi: 10.1111/j.1365-4632.2012.05477.x
Conflicts of interest: MAG acts as a consultant, receives grant funding or is on the speaker bureaus for Novartis, NovaBay, Pfizer, Stiefel Pharmaceuticals, Astellas, Merck Pharmaceuticals and Humco Holdings.
- Issue published online: 17 APR 2013
- Article first published online: 17 APR 2013